Researchers led by bioengineering professor David Gough at the University of California-San Diego have reported, in a paper in Science Translational Medicine, that they implanted a wireless telemetry continuous glucose monitor (CGM) in two pigs (222 and 520 days, respectively) and the device was successfully reporting glucose levels to an external receiver.
Following human testing and FDA approval, devices such as these could replace similar systems that are external to the body with a needle attachment that pierces the skin to take measures. Combined with potential transdermal or intranasal insulin administration, this technology could lead to less sticking and poking of people with diabetes. Read more »
*This blog post was originally published at Medgadget*